ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $32,691 | -30.6% | 917 | -10.2% | 0.00% | 0.0% |
Q2 2023 | $47,099 | +64.0% | 1,021 | +42.6% | 0.00% | 0.0% |
Q1 2023 | $28,712 | -57.6% | 716 | -51.0% | 0.00% | -50.0% |
Q4 2022 | $67,734 | +170.9% | 1,462 | +143.7% | 0.00% | +100.0% |
Q3 2022 | $25,000 | +78.6% | 600 | +151.0% | 0.00% | – |
Q2 2022 | $14,000 | +40.0% | 239 | +69.5% | 0.00% | – |
Q1 2022 | $10,000 | +25.0% | 141 | +50.0% | 0.00% | – |
Q4 2021 | $8,000 | +300.0% | 94 | +248.1% | 0.00% | – |
Q3 2021 | $2,000 | +100.0% | 27 | +350.0% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 6 | -64.7% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 17 | -22.7% | 0.00% | – |
Q4 2020 | $3,000 | – | 22 | +266.7% | 0.00% | – |
Q3 2020 | $0 | – | 6 | +500.0% | 0.00% | – |
Q3 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 1 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |